Examining patient specific factors associated with inpatient hospital length of stay for solid tumor oncology patients from low socioeconomic communities in Milwaukee, WI.

Authors

null

Sailaja Kamaraju

Froedtert Health and Medical College of Wisconsin, Milwaukee, WI

Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John A. Charlson, Aniko Szabo, Donggwan Lee, Thomas Wetzel, Kevin Richardson, Kathleen Jensik, Steve Power, Grace Campbell

Organizations

Froedtert Health and Medical College of Wisconsin, Milwaukee, WI, Medical College of Wisconsin, Milwaukee, WI, Froedtert and Medical College of Wisconsin, Milwaukee, WI, Froedtert Memorial Hospital, Milwauee, WI, Yale School of Nursing, Orange, CT, Duke University, Durham, NC, Pitt School of Health and Rehab Sciences, Pittsburgh, PA

Research Funding

Other
ASCO-QTP-QI, Niarchos Training Grant and Institutional (MCW) Faculty Vitality Award (to Dr. Kamaraju, Institutional (MCW) Faculty Vitality Award (to Dr. Kamaraju)

Background: In a retrospective analysis at the Medical College of Wisconsin’s Cancer Center, we identified longer inpatient length of stay (LOS) for patients residing in low-socioeconomic (SES) ZIP Codes in Milwaukee County compared to their high-SES counterparts in 2020 (7.3 days compared to 7.1 days). Under the auspices of American Society of Clinical Oncology’ Quality Training Program (QTP) initiative, this study examined specific factors related to prolonged LOS for solid tumor oncology patients. Methods: This analysis includes initial CY20 LOS medical record data for select patient service areas. Supplemental data includes disease registry data, diagnostic data, and SES data determined by patient ZIP Code. We identified patients 18 years and older with a diagnosis of common oncologic malignancies from 1/1/2020-12/31/2020 (breast, gastrointestinal (GI), genitourinary (GU), gynecologic (GYN), head and neck (H&N), and lung cancers). Poisson regression models with robust standard errors were used to compare the LOS index (LOSi) between groups of patients based on race, SES group, primary payer, and BMI. Results: A total of 1,637 patients with solid tumor diagnosis admitted to hematology and oncology units were identified. The LOSi did not vary significantly by race (range 0.95 – 1.07, p = 0.40) or primary payer (range 0.99 – 1.04, p = 0.59), but lower SES groups tended to have longer LOSi, with LOSi ratio above 1 compared to high SES (low SES: 1.16, p = 0.2; medium-low SES: 1.24, p = 0.06). Among patients with breast cancer diagnosis, Black (LOSi = 1.24, p = 0.01), medium-low SES (LOSi = 1.46, p = 0.02), Medicaid (LOSi = 1.40, p = 0.00), underweight (LOSi = 1.66, p = 0.00), and overweight (LOSi = 1.23, p = 0.01) patients had slightly longer LOSi, with LOSi ratio above 1. Among patients with H&N cancer diagnosis, Black patients (LOSi = 0.77, p = 0.02) had slightly shorter LOSi, with LOSi ratio below 1. The LOSi did not vary significantly by other factors for patients with H&N cancer diagnosis or the other common oncologic malignancies evaluated. Conclusions: This study shows how patient-specific factors such as race, SES, primary payer, and BMI contribute to inpatient LOS. Healthcare systems may benefit by addressing patient-specific barriers and factors such as body mass index, SES and SDH, to reduce hospital LOS.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Quality Improvement Research and Implementation Science

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 232)

DOI

10.1200/JCO.2020.39.28_suppl.232

Abstract #

232

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

First Author: Akshit Chitkara

Abstract

2024 ASCO Genitourinary Cancers Symposium

Association of body-mass index (BMI) with age, PSA, and survival in metastatic prostate cancer.

First Author: Martin W. Schoen

First Author: Ayobami Gbenga Olafimihan